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ABSTRACT
The ability of influenza A virus to cause global pandemics has been a great concern
throughout history and poses a serious health risk worldwide. Pandemic outbreaks
throughout history, such as the Spanish flu of 1918, have claimed the lives of millions of
people worldwide. The current outbreak of avian influenza (H5N1) that began in 1997 is
still claiming lives, and therefore efforts to understand the mechanisms of pathogenesis in
this highly virulent virus are of the utmost importance. According to the World Health
Organization, there have been 447 reported H5N1 human cases, resulting in 263 deaths.
The pathology of H5N1 infection includes pulmonary edema and diarrhea. Large scale
sequencing of influenza A viruses revealed that nonstructural protein 1 (NS1) contains a
class I PDZ motif. The NS1 proteins of avian origin contain the PDZ motif ESEV, which
has been found to bind several cellular PDZ domain proteins. The interaction of NS1 and
host proteins via the PDZ motif is a determinant in the virulence of influenza viruses of
avian origin. Consistent with the clinical symptoms, this study is the first to show that
the NS1 protein of A/chicken/Vietnam/C58/04 binds synapse-associated protein-97
(SAP-97), an adherens junction protein, in a PDZ motif-dependent manner. In H5N1
infected tissues, the SAP-97 distribution is reorganized. Functionally, the interaction of
NS1 and SAP-97 results in the loss of epithelial barrier function. This mechanism helps
to explain why the two disease states, pulmonary edema and diarrhea, in which epithelial
barrier is compromised, are both common in human H5N1 infection.
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CHAPTER 1. INTRODUCTION
1.1

Influenza A Viruses

Influenza A viruses belong to the family Orthomyxoviridae. The viruses in this
family are defined by their RNA genome, which is negative-sense (complementary to the
mRNA sense), single stranded, and segmented [1]. There are three genera, or types, of
influenza viruses: A, B, and C. Influenza A and B viruses have 8 gene segments, while
influenza C has 7 gene segments. The 8 viral gene segments of influenza A encode 11
gene products. These include the PB1, PB1-F2, PB2, PA, HA, NP, NA, M1, M2, NS1,
and NS2 proteins.
1.1.1

The Proteins of Influenza A Virus

PB1, PB2, and PA are the influenza polymerase proteins. PB2 polymerase is
encoded by the largest RNA segment (segment 1), while PA is encoded by segment 3.
PB1 and PB1-F2 are encoded by segment 2. Together, the polymerase proteins form a
complex necessary for viral RNA-dependent RNA polymerase activity [1,2]. PB1-F2
protein is only about 90 amino acids long and is encoded by the +1 reading frame of the
PB1 gene segment [3,4]. PB1-F2 has been implicated in contributing to viral
pathogenesis in certain influenza strains.
The nucleoprotein (NP) is encoded by viral RNA segment 5. NP plays a major role
in binding and encapsidating the viral RNA to form ribonucleoprotein (RNP). NP is one
of the most abundant proteins in the virion and in infected cells [1].
The matrix protein (M1) and the ion channel M2 are both encoded from RNA
segment 7. Matrix is the most abundant protein in the influenza virion and is also the
most highly conserved protein of all the influenza A proteins [2,5]. M1 binds RNP to
shut off transcription. M2 protein is an ion channel that is inserted into the virus
membrane. The main function of M2 is to transport protons into the virion during
uncoating. M2 forms a tetramer, and on the surface of the infected cell it is found in
large amounts, but is found in smaller amounts on the virion [2].
The nonstructural proteins, NS1 and NS2, are encoded by the smallest RNA
segment, segment 8. NS1 protein is produced from the unspliced RNA, while NS2 is
produced from spliced RNA. Due to an overlapping reading frame, these 2 proteins have
the same 9 amino acids at their amino termini. These proteins were originally named
nonstructural because they were both thought to be abundantly synthesized in the infected
cell but not incorporated into virions. However, it has been found that NS2 binds to M1
and is incorporated into virions [5]. NS2 contains a nuclear export signal and plays a role
in nucleo-cytoplasmic export of RNP. Therefore, it is also known as the nuclear export
protein (NEP) [6]. NS1 has been detected in cells only after active infection. The
multifunctional protein NS1 will be discussed in greater detail below.
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Hemagglutinin (HA) is encoded by RNA segment 4. The hemagglutinin protein is a
membrane protein that is necessary for binding the virion to the receptor on the host cell.
The HA protein undergoes posttranslational modification, such as glycosylation,
acylation, and proteolytic cleavage. HA is cleaved into 2 subunits by host-produced
proteases. This cleavage by host proteases is essential for infectivity. HA also forms the
major surface antigen and is the main target of the host immune response [1,5].
The neuraminidase (NA) protein is encoded by RNA segment 6. Like HA, it is an
integral membrane glycoprotein and is also a major surface antigen. The main function
of NA is to cleave terminal sialic acid residues from glycoproteins. This enables nascent
virions to free themselves from the host cell receptors of the infected cells from which
they arose [2].
Influenza viruses have a standardized naming system and are named according to
genus, animal species the virus was isolated from, geographical location, isolate number,
and year. Influenza A viruses are further classified by hemagglutinin (H) and
neuraminidase (N) antigenic subtypes. Of these subtypes, there are 16 distinct
hemagglutinin antigens (H1-H16) and 9 distinct neuramidase antigens (N1-N9) [7].
According to the conventional naming scheme, the virus, A/chicken/Vietnam/C58/04
(H5N1), is of influenza type A and was isolated from a chicken in Vietnam in 2004.
1.1.2

Disease Symptoms of Influenza Virus Infection

Influenza A virus infection in humans is highly contagious and causes a respiratory
disease commonly referred to as the flu. Symptoms include high fever, inflammation of
the trachea and upper respiratory tree, coryza, headache, and malaise. Symptoms often
linger for 7 to 10 days [8]. Influenza B and influenza C viruses also cause respiratory
disease in humans. Influenza B viruses have caused local epidemics, but the number of
hospital admissions is far less than seen with influenza A viruses [1,9]. Influenza C virus
causes less severe disease than the other influenza types because most individuals have
developed antibodies against influenza C by early adulthood [1,10].
Although influenza B and C cause disease in humans, unlike influenza A virus, they
do not have the ability to cause global pandemics. There are two main reasons influenza
A viruses are able to cause global pandemics while influenza B and C are not. The first
main reason for this is the ability of influenza A virus to escape neutralizing antibodies
through antigenic drift and shift. The second main factor is that influenza A virus has a
wide species tropism [10]. Influenza B and C viruses mainly infect humans, although
influenza B virus has been recovered from seals, and influenza C virus has been
recovered from pigs [11,12]. Influenza A viruses on the other hand, infect a wide variety
of animal species, including humans, swine, horses, dogs, cats, sea mammals, and, most
importantly, birds [1,2]. Aquatic birds are thought to be the primary reservoir for all
influenza A viruses which can be thought of as an avian virus that infects many other
species [2]. Influenza B and C viruses, on the other hand, have not been recovered from
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avian hosts [2]. Of the 16 hemagglutinin and 9 neuraminidase subtypes, only a few
combinations of these have been recovered from humans, while all combinations of the
subtypes are found in birds [2].
1.1.3 Antigenic Shift and Antigenic Drift
One remarkable feature of influenza viruses are their ability to generate new
antigenic variants that evade host immunity causing annual epidemics and worldwide
pandemics. The processes that make this happen are antigenic drift and antigenic shift.
Antigenic drift results from the accumulation of point mutations during viral replication.
Point mutations accumulate because the influenza RNA polymerase complex does not
have any proofreading activity. The mutation rates are extremely high, and have been
observed to be greater than 10-3 substitutions per site per year [13]. There is little
difference between the mutation rates of avian influenza viruses and mammalian
influenza viruses [13]. A host can develop immunity to influenza virus by developing
antibodies to the HA and NA proteins. Antigenic drift gives the virus an advantage by
changing the surface epitopes, allowing the virus to evade the preexisting protective
immune response of the host. Further, certain regions of the surface proteins, such as
antibody binding sites, are more susceptible to accumulating mutations than other sites of
the same protein [14].
The process of antigenic shift is only seen in influenza A viruses. Antigenic shift is
the process by which the virus obtains new gene segments by reassortment of two or
more different subtypes of influenza viruses [15]. This occurs when more than one
influenza virus isolates infect the same host cell. Antigenic shift results in a virus with a
completely different antigenic structure that has not been seen to circulate in the
population before and may play a major role in causing world wide pandemics and
epidemics [14].
1.1.4 H5N1
In 1997, a highly pathogenic influenza virus causing severe respiratory disease
resulted in the death of a small child in Hong Kong. Earlier that year, three Hong Kong
chicken farms reported a highly lethal epidemic of avian influenza. It was subsequently
found that a subtype of influenza A virus, H5N1, was responsible for both the human
and chicken deaths [16]. Efforts to control this outbreak were quickly undertaken, but
despite increased supervision of poultry farms more human cases of H5N1 began to
appear. Therefore, in December 1997 the Hong Kong government decided to cull all the
chickens in Hong Kong [16]. With the culling of the chickens, the H5N1 outbreak was
brought under control. In total, the 1997 H5N1 outbreak in Hong Kong infected 18
people and resulted in 6 deaths. This outbreak of H5N1 was distinctive in that the virus
was transmitted directly from chickens to humans without first infecting an intermediate
mammalian host [17,18]. Most of the H5N1 patients had close contact with dead or sick
birds prior the onset of illness [19].
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In 2003, a resurgence of H5N1 virus caused an epidemic in domestic poultry that has
spread from Asia to Europe. Human cases of H5N1 also re-emerged in 2003, and new
cases of human H5N1 infection are being reported to the World Health Organization
(WHO) to date. Of the confirmed human cases reported to WHO, H5N1 claimed the
lives of about 60% of those infected [20].
In humans, the incubation period of H5N1 is typically between 2 and 5 days, and the
duration from the onset of symptoms to death is about 9 days [19]. Clinical features of
the H5N1 virus in human infection vary from individual to individual. They include
respiratory symptoms, high fever, malaise, cough, sore throat, and diarrhea as well as
acute respiratory distress syndrome (ARDS) and multi-organ dysfunction syndrome
(MODS) [19,21,22]. H5N1 infection differs from seasonal influenza in that
gastrointestinal symptoms are a common early clinical feature, including abdominal pain,
vomiting, and watery diarrhea [19]. A large number of H5N1 patients present with
diarrhea. In fact, one retrospective report documenting the clinical features of H5N1 in
Vietnam found that diarrhea was more common in fatal than nonfatal H5N1 cases [23].
Autopsies of H5N1 victims have revealed diffuse alveolar damage, edema, fibrous
exudates, hyaline membranes, and hyperplasia of type II pneumocytes in the lungs
[22,24,25]. Histopathological features in the lungs have included cystically dilated
airspaces, apoptosis of alveolar epithelial cells, pleuritis, and desquamation of epithelial
cells into the alveolar spaces [26]. Pathology has also been noted in other organs such as
the spleen, bone marrow, liver, and lymph nodes [22,24,26]. Our study focuses on the
clinical features of pulmonary edema and diarrhea and therefore the lung and intestines.
In H5N1 patient tissues, viral antigens and genomic RNA have been found in various
tissues. Viral antigens and viral RNA have been detected in the respiratory tract. Among
cell types found to be positive for viral antigen and sequence are epithelial cells of the
trachea and type II pneumocytes [26]. Viral RNA has been detected in the brain, and
viral antigens have been found in neurons [24,25,27]. Further, virus has been isolated
from cerebrospinal fluid [28]. Viral RNA specific for the HA protein was found in the
spleen [25]. Viral antigens and viral sequences have been found in both the large and
small intestine [25,27]. Viral RNA has also been detected in rectal swabs of patients
[28,29]. One report confirms that H5N1 can replicate in the gastrointestinal tract even in
patients that don’t experience diarrhea [25].
Attempts to elucidate the molecular mechanisms for viral pathogenesis of H5N1
have been pursued since the beginning of the outbreak in 1996. Among the findings are
the single amino acid change in the RNA polymerase PB2 at position 627 and an amino
acid change at position 66 of the PB1-F2 protein both of which modulate virulence [3032]. The hemagglutinin protein has also been shown to be an important mediator of
virulence in H5N1 viruses. Increased cleavability of the receptor by ubiquitous proteases
has been shown to correlate with increased virulence [30,32]. NS1 has also been reported
to play a role in the virulence of H5N1. Single amino acid changes in NS1 at residues 42,
92, and 149 have been found to increase the virulence of H5N1 [33-35]. Details of the
H5N1 NS1 studies will be discussed in more detail in the following section.
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1.2 NS1 Protein
Nonstructural protein 1 (NS1) is encoded by the smallest gene segment (vRNA
segment 8) of influenza A virus, which encodes both the NS1 and NS2/NEP proteins.
NS1 is made only during viral infection and has not been found in mature virions. NS1 is
synthesized during early viral infection, with protein synthesis reaching a peak at 2.5
hours post infection and remaining high for at least 3 hours after it peaks [36]. NS1
protein has been shown to have many functions and has been reported to interact with
various cellular proteins.
1.2.1 Structure of NS1 Protein
NS1 has two major domains, the RNA binding domain and the effector domain
(Figure 1.1). The RNA binding domain of NS1 encompasses the N-terminal 73 amino
acids. The RNA binding domain of NS1 binds double stranded RNA (dsRNA) with very
low affinity compared to other cellular proteins that are able to bind dsRNA [37,38].
Structural studies of the RNA binding domain have found that it forms a homodimer in
solution and is composed of 3 alpha helices [39]. Dimerization of the RNA binding
domain is critical to its function in binding dsRNA, and each homodimer of NS1 binds
dsRNA in a 1:1 ratio [38,40].
NS1 proteins from different viruses vary in length of the C-terminus; however,
amino acid 74 to the C-terminal amino acid makes up the effector domain. Studies on the
structure of the effector domain of NS1 have found that, like the RNA binding domain, it
also forms a homodimer [41,42]. This has been found to be the case for NS1 of both
human and avian influenza viruses [41,42]. None of the structural studies of the effector
domain were able to crystallize the last 25 amino acids of the protein. It is thought that
the C-terminus of NS1 is highly disordered and only adopts an ordered structure upon
binding to other proteins [43].
1.2.2 Role of NS1 in mRNA Processing, Translation, and Inhibition of Nuclear Export
NS1 and NS2/NEP are both encoded by vRNA segment 8. NS1 is encoded by the
unspliced mRNA, while NS2/NEP is encoded by the spliced transcript. NS1 has a much
higher expression level than does NS2/NEP because only about 10% of the viral mRNA
is spliced [44]. In fact, NS1 inhibits splicing of its own viral pre-mRNA in vitro and in
vivo [43,45,46].
NS1 regulates posttranslational processing of RNA polymerase II-driven mRNA
transcripts. NS1 inhibits the splicing of mRNA, and it blocks the export of mRNAs that
contain 3’ poly(A) tails [45]. It was found that both of these functions of NS1 were
attributable to the effector domain of the protein [47]. Further studies revealed that NS1
binds the cleavage and polyadenylation specificity factor (CPSF). CPSF is important in
pre-mRNA processing and is necessary for cleavage and addition of the poly(A) tail. By
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Figure 1.1 Pictorial representation of NS1 protein.
Pictorial representation of NS1 protein of influenza A/chicken/Vietnam/ C58/04 used
in these studies. NS1 protein of this virus contains the PDZ motif ESEV commonly
found in highly pathogenic H5N1 viruses.

6

binding to CPSF, NS1 prevents the addition of the poly(A) tail and, as a result, mRNAs
are not exported from the nucleus [48]. Despite this inhibition by NS1, some host premRNAs in the nucleus are still cleaved and short poly(A) tails are added to them. NS1 is
able to block further elongation of these poly(A) tails by targeting the poly(A)-binding
protein II (PABII) [49]. The binding sites for these protein-protein interactions were
mapped. NS1 amino acid residues 180-215 are necessary for binding CPSF. The 23 Cterminal amino acids of NS1 are important for binding PABII [50]. During influenza
virus infection, cellular mRNA and pre-mRNAs trapped in the nucleus are degraded,
while viral RNA which is selectively exported becomes the predominant mRNA to reach
the translation machinery [44].
In addition to targeting proteins involved in processing cellular pre-mRNAs, NS1 is
able to bind and inhibit proteins that play crucial roles in the mRNA nuclear export. NS1
is able to bind p15, NXF1, Rae1, E1B-AP5, and Nup98—all of which form a complex
and are import protein constituents of the nuclear export machinery [51]. The p15
protein was found to interact with residues in the effector domain of NS1. Both RNA
binding domain and effector domain of NS1 were needed to bind the other proteins in the
complex [51].
During influenza virus infection there is a global decrease in cellular protein
expression. This effect has been attributed to the NS1 protein due to its ability to block
mRNA processing and nuclear export. However, NS1’s role in translation has also been
studied and it has been found that NS1 enhances translation initiation of viral mRNAs
[52]. It is thought that NS1 is able to enhance translation of viral mRNAs by interacting
with 5’ extracistronic sequences in the viral mRNA [52]. Another report has shown that
NS1 can also augment translation of cellular proteins and that this effect was not
promoter specific [53]. NS1’s ability to enhance translation may be attributed to NS1’s
ability to block protein kinase R (PKR) activity, as PKR acts to block translation in virus
infected cells [53]. Further, it was shown that the global shut-off of protein expression
was not attributable to NS1 as cells infected with an NS1 deficient virus still have a
global reduction in host protein expression [53].
1.2.3 NS1 Acts to Subvert the Cellular Immune Response
NS1 is a multifunctional protein, and among its many functions, NS1 plays a major
role in subverting the immune system. There are many defenses that the infected host
cell activates upon virus infection. One early cellular response to viral infection is the
cellular transcription, activation, and translocation of interferon regulatory factors (IRFs)
from the cytoplasm to the nucleus [54]. In influenza A virus infection, NS1 counteracts
this innate immune response by blocking the maturation of mRNAs that encode the IRFs
[55]. NS1 accomplishes this by inhibiting the 3’ end processing of cellular pre-mRNAs
by binding to the cleavage and polyadenylation specificity factor (CPSF) and the
poly(A)-binding protein II (PABII) [37].
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Another method that host cells use to detect viral replication is through cellular
proteins that detect dsRNA made during virus infection. One such pathogen detector, the
retinoic acid-induced gene I product (RIG-I), is targeted by NS1 [56]. It has been
proposed that NS1 blocks interferon-β (IFN-β) production through forming a complex
with RIG-I, although this interaction is not direct [56].
NS1 is also able to inhibit the activation of protein kinase R (PKR). PKR is
activated in infected cells in response to dsRNA. PKR plays a role in inhibiting viral
replication by phosphorylating the α-subunit of eIF2, a protein important in translation
initiation [37]. NS1 interacts directly with PKR, through residues in its effector domain.
The RNA binding domain of NS1 may also play a role in inhibiting PKR activation; in
vitro studies have shown the RNA binding domain to be sufficient for inhibition of PKR
[37].
The NS1 RNA binding domain also functions to subvert the innate immune response
through another pathway. 2’-5’-oligoadenylate synthetase (OAS) is activated by dsRNA
made during viral replication. OAS in turn activates RNase L which degrades RNA, both
cellular and viral, and therefore inhibits viral replication [57]. NS1 acts to inhibit the
OAS/RNase L pathway by out competing OAS for binding of dsRNA [58]. Inhibition of
the OAS/RNase L pathway is thought to be the principal function of NS1’s RNA binding
domain [58].
1.2.4 NS1 and Apoptosis
Differing reports have been published on the role of NS1 in apoptosis. While some
studies have reported that NS1 has pro-apoptotic functions, others have reported that NS1
has anti-apoptotic functions. One theory that integrates the varying data is that NS1 may
suppress apoptosis during early viral infection while promoting it during later time points
of infection. Others maintain that the conflicting data are a result of the different
experimental procedures, cell types, virus strains, and NS1 constructs used [43].
Two studies have reported that NS1 induces apoptosis in cultured epithelial cells.
The first study found that RNA binding domain is necessary for the NS1 protein to
induce apoptosis [59]. The second study reported that NS1 induces apoptosis through the
death receptor caspase pathway [60]. A number of studies also report that NS1 is antiapoptotic [61-64]. These studies also have used various viral constructs and cell types.
One report concluded that the anti-apoptotic function of NS1 is dependent on its ability to
block IFN [61]. In human macrophages, it seems that the NS1 protein is working to
block apoptosis through the inhibition of caspase-1 [62].
Another mechanism by which NS1 may be inhibiting apoptosis is through the
PI3K/Akt signaling pathway. The major role of PI3K is to phosphorylate membrane
phosopholipids, resulting in the generation of phosphatidylinositol-3,4,5-triphosphate
(PIP3), an important signaling mediator. PI3K is activated upon binding of its regulatory
subunit, p85. Several studies have revealed that NS1 is able to bind and activate

8

phosphatidylinositol-3-kinase (PI3K) by binding the p85β subunit of PI3K [64-67]. NS1
activation of PI3K is important both for virus replication and inhibition of apoptosis
through inhibiting the caspase-9 apoptotic pathway [64,65].
1.2.5 NS1 of H5N1
Since the beginning of the H5N1 outbreak, efforts have been underway to elucidate
the molecular mechanisms that contribute to the pathogenicity of this lethal virus.
Several reports have shown that NS1 plays a role in the virulence of H5N1. Early studies
showed that recombinant viruses containing the NS1 of H5N1 had increased
pathogenesis in pigs. A single amino acid change at position 92 from aspartic acid to
glutamic acid was found in the NS1 proteins of these virusesm, and this single amino acid
change made these viruses more resistant to interferon (IFN) and tumor necrosis factor-α
(TNF- α) [35]. Further characterization of these viruses in a mouse model found that
viruses that contained the NS gene of H5N1 induced the production of inflammatory
cytokines while decreasing the production of anti-inflammatory cytokines [68].
Other studies have uncovered other amino acid residues of NS1 that play a role in
increasing the pathogenesis of H5N1. Using recombinant viruses in a mouse model, it
was found that a single amino acid change at residue 42 also increased virulence of H5N1
viruses. A substitution of serine for proline at this position increases virulence by
antagonizing the induction of IFN though the IRF-3 pathway [34].
By utilizing a chicken model, it was found that amino acid 149 of NS1 also plays a
role in the virulence of H5N1 viruses. In this study, only recombinant viruses that
contain the amino acid alanine at position 149 of NS1 were able to cause disease and
death in chickens [33]. It was also shown that alanine at position 149 correlates with the
ability of these viruses to inhibit the IFN response in chicken embryo fibroblasts [33].
1.2.6 The PDZ Motif of NS1
In 2006, a group at St. Jude Children’s Research Hospital (Memphis, TN) undertook
the task of sequencing 336 avian influenza viruses. The viruses sequenced in this project
were collected between 1976 and 2004. Among the viruses sequenced, all 16 HA and 9
NA subtypes were represented. This large-scale sequencing revealed that avian viruses
have greater sequence variability in their HA, NA, PB1-F2, and NS1 proteins than
influenza viruses of non-avian origin [69]. This study also identified that the NS1 protein
of avian influenza A viruses contain a class I PDZ motif. By assessing the sequences of
NS1 protein from avian, swine, and human viruses, this study found that a majority of
NS1 proteins from avian influenza viruses contain the PDZ motif ESEV while the NS1
proteins of human influenza viruses contain the PDZ motif RSKV. Further, it was found
that the highly virulent viruses isolated from the 2003-2004 H5N1 outbreak in Hong
Kong and Vietnam had the PDZ motif ESEV [69]. Binding studies revealed that NS1
protein containing the PDZ motif ESEV was able to bind 24 human PDZ proteins while
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the NS1 protein containing the PDZ motif RSKV was not able to bind these proteins with
great affinity [69]. The PDZ proteins NS1 was found to bind in this study include
Partitioning-defective protein 3 (Par3) which plays a role in cell polarity and Lim motifcontaining protein kinase 2 (LIMK2), a protein that plays a role in microtubule
disassembly [70]. Based on these findings, it was hypothesized that influenza viruses in
which NS1 contains a PDZ motif of avian origin may interact with host PDZ proteins,
thus disrupting normal cellular pathways and leading to greater mortality rates [69].
Further investigation into the role of NS1’s PDZ motif showed that the PDZ motif of
NS1 plays a role in increasing virulence of influenza viruses. Using a reverse genetics
system, several known PDZ motifs of NS1 were incorporated into the NS1 protein of the
human influenza virus A/WSN/33 [71]. This study showed that influenza viruses, in
which NS1 contains the PDZ motifs EPEV or ESEV, have increased virulence and
pathogenicity in infected mouse lungs. These are the same PDZ motifs found in the
H5N1 outbreaks in 1997 and 2003, respectively. The NS1 PDZ motif, KSEV, from the
1918 H1N1 Spanish flu was also found to increase pathogenicity of the virus in infected
mouse lungs [71]. Influenza virus in which the NS1 PDZ motif was truncated showed
less pathogenicity in the infected mice. This study also investigated whether the
differences in pathology seen in mouse lungs infected with the recombinant viruses were
due to an altered ability to circumvent the IFN response; however, it was shown that this
increased pathogenicity is not caused by changes in the interferon response [71].
Therefore, it is likely that interactions of NS1 with other host proteins may be responsible
for the increased virulence seen with influenza viruses that contain a PDZ motif of avian
origin in the NS1 protein.
1.3 PDZ Domains and Motifs
PDZ domains are modular protein-protein interaction domains that were first
recognized as regions of sequence homology in the 3 proteins postsynaptic density-95
(PSD-95), discs large (Dlg)—the Drosophilia septate junction protein, and zona
occludens-1 (ZO-1)—the epithelial tight junction protein. Therefore the acronym PDZ
was created. In the literature, PDZ domains are also referred to as discs large homology
repeat, or DHR domains, and GLGF repeats for the highly conserved amino acid
sequence within the domain [72]. PDZ domains are typically about 90 amino acids long
and show substantial sequence variation. The significant sequence variation of PDZ
domains may be what gives these diverse proteins very specific binding capabilities [73].
The structures of at least 8 PDZ domains have been resolved. Through these studies, we
have learned that these domains are compact. The N- and C-termini of these protein
domains are brought together in the folded state [72]. PDZ domains fold into six antiparallel β-strands that are framed by two α-helices [72,73]. So far, the human genome
has been found to encode more than 250 PDZ domains in over 100 proteins [74]. PDZ
proteins assemble together to form supramolecular complexes that function in localized
signaling and are found in high abundance at points of cell-cell contact [73,75]. PDZ
proteins are also involved in key processes, such as maintenance of cell polarity and the
regulation and trafficking of membrane associated proteins [73,75].
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While PDZ domains have been found to interact with phospholipids and internal βhairpin structures, a majority of PDZ domains mediate interactions with proteins
containing a sequence-specific carboxy-terminal binding motif (or PDZ motif)[73,76,77].
There are three classes of PDZ motifs based on the specificity of the ligand. For class I
PDZ motifs, this sequence is X-S/T-X-V/L, where X is any amino acid [73]. Class II
PDZ motifs have the carboxy-terminal consensus sequence X-φ-X-φ, while class III PDZ
motifs have the consensus sequence X-D-X-V [73]. X represents any amino acid, while
φ represents a hydrophobic amino acid residue. PDZ domains preferentially bind Cterminal peptides through interactions with the highly conserved GLGF motif found in
PDZ domains. Protons found in the GLGF motif form hydrogen bonds with the terminal
carboxylate group of the PDZ motif—thus giving rise to the specificity for C-terminal
peptides [73]. Different PDZ domains have different stringency requirements for peptide
binding, giving rise in part to a wide range of binding affinities between PDZ domains
and their ligands. Binding affinities measured for PDZ domains and motifs have ranged
from a Kd of 10-8 M to 10-6 M [73]. Binding affinities in this range are considered
modest and make PDZ domain/motif interactions ideal for processes that must be
regulated and reversible [72]. Although much has been uncovered about PDZ domain
interactions, relatively few proteins have been studied. Therefore, future studies are
likely to reveal much more about these physiologically important interactions.
1.4 Adherens Junctions
The adherens junction is made up a large protein complex and has many functions,
including initiating and maintaining cell-cell adhesion, regulating the actin cytoskeleton,
and intracellular signaling. Cell-cell adhesion is indispensable to epithelial cell function
and morphology and is essential in the process of epithelial cell polarization. Adherens
junction formation is also crucial for the formation of tight junctions in polarized
epithelial cells. The adherens junction initiates cell-cell contact though the binding of Ecadherin proteins on neighboring cells [78,79].
1.5 SAP-97 Protein
Synapse associated protein-97 (SAP-97) belongs to the family of proteins designated
membrane-associated guanylate kinase (MAGUK). Each protein in the MAGUK family
has multiple protein-protein interaction domains, including three PDZ domains, a src
homology 3 (SH3) domain, and a guanylate kinase (GUK)-like domain (Figure 1.2)
[80,81]. The guanylate kinase-like domain of SAP-97 is referred to as such because it
was found that this domain does not actually encode an active guanylate kinase despite
high sequence similarity to such domains [82]. Each protein in the SAP family is located
at synapses. SAP-97 is the only protein in the SAP family that is also found in epithelial
cells, where it localizes to cell-cell junctions [80]. Proteins homologous to SAP-97 have
been studied in other animal systems. In Drosophila, this protein is known as the discs
large (Dlg) tumor suppressor. In Caenorhabditis elegans, this protein has been
designated DLG-1, whereas in mammalian cells it is referred to as SAP-97. SAP-97 is
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Figure 1.2 Pictorial representation of SAP-97 protein.
SAP-97 belongs to the MAGUK family of proteins and has three PDZ domains
(yellow), an SH3 domain (purple), and a GUK-like domain (green). The above numbers
correspond to the amino acid residues of the individual PDZ domains.
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also referred to as human discs large (hDlg) in human systems; however, all these
proteins are homologous and serve similar functions. SAP-97 was first cloned and
characterized in 1994, and it was immediately recognized to bind protein 4.1, a
cytoskeletal protein that also localizes to adherens junctions [81]. SAP-97 is a
multifunctional protein. In neurons, SAP-97 interacts with the NMDA receptor and
inward rectifying potassium channels [80]. SAP-97 also acts as a tumor suppressor in
some cell types [83].
1.5.1 Tissue Distribution of SAP-97
Mammalian characterization of SAP-97 reveal that SAP-97 mRNA is expressed in
heart, testis, muscle, liver, and lung tissues of rats [84]. In humans, SAP-97 mRNA or
protein is detected in heart, muscle, liver, lung, spleen, kidney, brain, and cervical
epithelia, as well as in T-cells and B-cells [81]. Immunohistological staining of intestinal
tissues show bright SAP-97 staining in the intestinal villi of rats [84]. In colons of mice
and human intestine, SAP-97 can be seen at the apical, lateral, and basolateral
membranes of epithelial cells [85,86].
SAP-97 staining can be seen at points of cell-cell contact in MCF-7 cells, a human
breast carcinoma cell line [81]. In T84 cells, a human intestinal epithelial cell line, SAP97 only localizes to sites of cell-cell contact, and staining is not seen at cell membranes
that are not in contact with other cells or in isolated cells [84]. In Caco-2 cells, SAP-97 is
found to localize at the lateral membrane where it co-localizes with E-cadherin [87].
1.5.2 Role of SAP-97 in Adherens Junctions and Cell Polarity
SAP-97 was first studied in Drosophila, where the protein is designated discs large
(Dlg). Early work revealed that mutations in Dlg lead to a loss in epithelial cell polarity
and intercellular adhesion [88]. This loss of cell polarity and cell-cell adhesion leads to
an overgrowth of the cells of the imaginal discs. The imaginal discs of the Drosophila
larvae are the epithelia that give rise to the adult appendages, including the legs,
antennae, and wings. A complete loss of Dlg in Drosophila leads to loss of the septate
junctions in the epithelia of larvae [89].
Work in Caenorhabditis elegans, has shown that DLG-1 is required for the
formation of adherens junctions [90,91]. DLG-1 is also required for the recruitment of
other adherens junction proteins, such as AJM-1 and cypin. In these studies it was noted
that other apical and basolateral proteins are properly localized even after complete
knockdown of DLG-1; therefore, it was concluded that DLG-1 plays a major role in the
establishment and maintenance of adherens junctions but does not play a role in cell
polarity [90].
The adherens junction plays a critical role in preserving adhesion between
neighboring epithelial cells. SAP-97 has been shown to play critical roles in adherens
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junction integrity, cell polarity, and epithelial cell differentiation and growth [85,8789,92-95]. SAP-97 is recruited to cell-cell adhesion sites in the intestinal epithelial cell
line Caco-2 [87]. In Caco-2 cells treated with EGTA to remove extracellular calcium,
SAP-97 distribution moves more intracellularly but remains associated with the actin
cytoskeleton [87]. In Caco-2 cells grown in low calcium media, SAP-97 staining is seen
in the cell cytoplasm [87]. It was also noted that E-cadherin mediates the recruitment of
SAP-97 to sites of cell-cell contact, although it does not bind SAP-97 directly [87]. The
amino terminal region (first 65 amino acids) of SAP-97 is important in localizing SAP-97
to the lateral membranes of epithelial cells [96].
Using human derived intestinal epithelial cell lines, it was shown that decreased
expression of SAP-97 through using RNAi leads to decreased E-cadherin, F-actin and
phosphatidylinositol 3-kinase (PI3K) at cell-cell contacts [85]. SAP-97 directly interacts
with the p85 regulatory subunit of PI3K [85]. This finding is of particular significance
because PI3K recruitment to the primordial adherens junction promotes junctional
assembly with components of the cytoskeleton, which stabilizes the adherens junction
and allows for differentiation of enterocytes [97]. Therefore, while in Drosophila, Dlg
plays a role in both cell polarity and adherens junctions; in mammalian cells and in C.
elegans, it is thought that this protein plays a major role in adherens junctions and a lesser
role in cell polarity.
1.5.3 SAP-97 Interacts with Other Viral Proteins
Interestingly, SAP-97 has been found to be a target of several viral proteins. These
viral proteins bind to SAP-97 through PDZ-motif dependent interactions. The first virus
studied was the subgroup D adenovirus type 9. This virus is able to induce estrogendependent mammary tumors in rats. The adenovirus type 9 viral protein, designated Ad9
E4 region ORF 1 protein (9ORF1), is the first viral protein identified to interact with
SAP-97 [98]. The protein 9ORF1 was found to bind strongly to the second PDZ domain
of SAP-97, but a weak interaction is also seen with PDZ1 and PDZ3 [98]. This
interaction was found to be dependent on the PDZ motif of 9ORF1, because proteins that
contained mutations in this region are not able to bind SAP-97 [98]. Remarkably, viruses
with mutations in the PDZ motif of 9ORF1 are not able to elicit tumors in rats [98].
Other oncogenic viruses also have proteins that posses a PDZ motif. Human T cell
leukemia virus type 1 (HTLV-1) is a retrovirus that causes aggressive and sometimes
fatal T cell leukemia in adults. The Tax oncoprotein of HTLV-1 contains the PDZ motif
ETEV, and has also been found to bind SAP-97 protein in a PDZ-dependent manner
[98,99].
The human papillomaviruses type 18 and 16 (HPV-18) are associated with genital
lesions and pose a high risk for cervical cancer. The E6 oncoprotein of HPV-18, which
contains the PDZ motif ETQV, binds SAP-97 through PDZ-mediated interactions
[98,100]. The PDZ motif of HPV-18 is able to bind all three PDZ domains of SAP-97
[100]. Similarly, the E6 protein of HPV-16 (PDZ motif ETQL) also binds SAP-97 PDZ
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2 in a PDZ-dependent manner [101]. For HPV-16, ability of the E6 oncoprotein to bind
SAP-97 correlates with the ability to transform rodent cells [101]. Not only does E6 of
HPV bind SAP-97, it targets SAP-97 for ubiquitin-mediated degradation [100,102].
While both E6 of HPV-16 and HPV-18 are able to target SAP-97 for degradation, the
increased binding affinity of HPV-18 E6 correlates with an increased level of degradation
of SAP-97 both in vitro and in vivo [102]. In immortalized human epidermal
keritinocytes, cells expressing E6 have a lower tendency to associate with neighboring
cells and had a loss of integrity of their adherens junctions [103].
1.6 Scope and Objective of Dissertation
The objective of this dissertation project was to investigate the PDZ motif-mediated
interactions of NS1 with host cell proteins and to determine if these interactions act to
modulate the pathogenicity of H5N1 influenza viruses. In this study, I demonstrate that
NS1 interacts with a host protein, SAP-97, through the PDZ motif. The data shed light
into the differences in pathology caused by H5N1 in the presence and absence of the NS1
PDZ motif. This study is the first to show that NS1 can interact with SAP-97, an
important adherens junction protein, and that the NS1 and SAP-97 interaction has a
functional consequence in disrupting epithelial barrier integrity.
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CHAPTER 2. PDZ-MOTIF MEDIATED PROTEIN INTERACTION OF NS1
AND SAP-97
2.1 Introduction
Human H5N1 infection is characterized by severe respiratory symptoms, including
pulmonary edema as well as severe diarrhea [21,23]. Both of these disease states result
from a breakdown in epithelial barrier function and are not common in seasonal influenza
outbreaks. Therefore, it was of interest to investigate whether the PDZ motif of NS1
(found in influenza viruses of avian origin) has a role in disrupting the structural integrity
of the epithelial barrier. We sought to identify PDZ proteins important in junctional
formation that may be interacting with NS1. For this study, NS1 protein of
A/Chicken/Vietnam/C58/04 containing the PDZ motif ESEV (NS1-WT) was used.
Constructs containing mutations in the PDZ motif were also generated. The construct
NS1-HuPDZ contains the PDZ binding motif RSKV found in the NS1 protein of
influenza A viruses of human origin [69], and NS1-ΔPDZ (stop codon at amino acid 223)
contains no PDZ binding motif. Several key tight junction and adherens junction proteins
were tested for their ability to bind NS1. Proteins examined all contained multiple PDZ
domains. We found that the tight junction protein ZO-1 was not able to bind NS1,
however we identified that NS1 of H5N1 binds SAP-97, and important adherens junction
protein.
2.2 Materials and Methods
2.2.1 Plasmid Construction
We obtained from the lab of Dr. Richard Webby, the p5H58-NS construct that
encodes NS1 of influenza A/chicken/Vietnam/C58/04. The p5H58-NS plasmid was used
as a template to create the pTriEx-4-NS1-WT, pTriEX-4-NS1-HuPDZ, and pTriEx-NS1ΔPDZ constructs by ligation independent cloning (LIC). The 5’ primer used for all three
reactions was 5’ GACGACGACAAGATGGATTCCAACACT 3’. The 3’ primer used
for creating NS1-WT was 5’ GAGGAGAAGCCCGGTTCAAACTTCTGACTCAAT 3’.
For NS1-HuPDZ the 3’ primer used was: 5’
GAGGAGAAGCCCGGTTCAAACCTTTGATCTAAT 3’. The reverse primer used to
create NS1- ΔPDZ was 5’ GAGGAGAAGCCCGGT TCACTCAATTGTTCTCGC 3’.
NS1 was amplified using the polymerase chain reaction (PCR). The PCR conditions
used were as follows: 2 minute denaturation at 95°C, 30 amplification cycles with an
annealing temperature of 62°C, and final extension of 72°C for 7 minutes. PCR products
were run on a 1% agarose gel to check for proper size (Figure 2.1). PCR products of the
correct size were excised from the gel and extracted using the Qiagen gel extraction kit.
Purified PCR products were treated with T4 DNA polymerase at room temperature for 30
minutes to create overhangs that are compatible with the vector. T4 DNA polymerase
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Figure 2.1 PCR products for cloning pTriEX-NS1 constructs.
Agarose gel to confirm proper size of PCR products for the cloning of pTriEX NS1WT, pTriEX-NS1-HuPDZ, and pTriEX NS1-ΔPDZ.
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was then heat inactivated by incubation for 20 minutes at 75°C. Each insert was then
incubated with pTriEX-4 LIC vector for annealing. Resulting plasmids were transformed
using NovaBlue competent E. coli. for DNA expression and Oragami competent E. coli
for protein expression. DNA was extracted from select colonies using a Qiagen miniprep
kit. Clones were screened for proper sequence at the University of Tennessee’s Molecular
Resource Center using the T7 promoter primer and the TriEXDOWN primer. The
pTriEx vector has N-terminal his6 and S tags. Using the same primers and template,
NS1-WT, NS1-HuPDZ, and NS1-ΔPDZ were also cloned into the LIC vector pET41.
The pET41 vector contains N-terminal Glutathione S-transferase (GST), his6, and S tags.
The UniProtKB/Swiss-Prot entry for SAP-97 (Q12959) was used to determine the
amino acids that encompass the individual PDZ domains. Of the full length SAP-97
protein, the sequence for amino acids 224 to 310 was used to create PDZ 1. Amino acid
residues of the full length SAP-97 protein used to make PDZ 2 were 319 to 405, and
amino acids 466 to 546 were used to create SAP-97 PDZ 3. The individual PDZ domains
of SAP-97 were cloned into the LIC vector pTriEX-4, which contains an N-terminal his6
and S tags. The plasmid pCDNA3 myc-SAP-97 was used as a template for this cloning.
This plasmid contains the full length human SAP-97 coding sequence with an N-terminal
myc tag. The primers used for SAP-97 PDZ 1 were 5’
GACGACGACAAGATGGAAATCACACACTTGAAAGGGGA 3’ for the forward
sequence and 5’ GAGGAGAAGCCCGGTTCACCTTCTTTTTACATACAAGCGTAC
3’ for the reverse sequence. The SAP-97 PDZ 2 primers forward and reverse were as
follows: 5’ GACGACGACAAGATGGAAATAAGCTCATTAAAGGTCCT 3’ and
GAGGAGAAGCCCGGTTCAGGGTTTTGCCACTTTCAATAAAC 3’. The forward
and reverse primers used for SAP-97 PDZ 3 were 5’
GACGACGACAAGATGAAAGTTGTTCTTCATCGTGGCTCA 3’ and
5’GAGGAGAAGCCCGGTTCATCGATATTGTGCAACAATTGTGAC 3’. The same
protocol for LIC cloning was used as stated above for pTriEX-NS1 constructs.
SAP-97 PDZ 1, PDZ 2, and PDZ 3 were subsequently cloned into the pGEX-4T-1
expression vector, which contains a GST tag in frame and upstream of the multiple
cloning site. The templates used for cloning were pTriEX-SAP-97 PDZ 1, pTriEX-SAP97 PDZ 2, and pTriEX-SAP-97 PDZ 3. Primers created for cloning the SAP-97 PDZs
into pGEX-4T-1 contained 5’ EcoRI and 3’ XhoI restriction site. The sequences for the
primers used were 5’ GGAATTCGAAATCACACTTGAA 3’ and 5’
CGGCTCGAGTCACCTTCTTTTTACATA 3’ for SAP-97 PDZ 1 forward and reverse,
respectively. The SAP-97 PDZ 2 primers used were
5’GGAATTCGAAATAAAGCTCATT 3’ for the forward sequence and 5’
CGGCTCGAGTCAGGGTTTTGCCACTTT 3’ for the reverse sequence. The SAP-97
PDZ 3 primers were as follows: 5’ GCAATTCAAAGTTGTTCTTCAT 3’ for the
forward sequence and 5’ CGGCTCGAGTCATCGATATTGTGCAAC 3’ for the reverse
sequence. PCR products were generated using the following conditions: 2 minute
denaturation at 95°C, 30 amplification cycles with an annealing temperature of 55°C, and
final extension of 72°C for 7 minutes. A 10 μL sample of the complete PCR reaction was
run on a 1% agarose gel to verify that the PCR inserts were of the proper size (Figure
2.2). The PCR products were then purified using a Qiagen PCR purification kit and
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Figure 2.2 PCR products for cloning pGEX4T1-SAP-97 PDZ constructs.
The agarose gel confirms proper size of PCR products for the cloning of pGEX4T1SAP-97 PDZ 1, pGEX4T1-SAP-97 PDZ 2, and pGEX4T1-SAP-97 PDZ 3.
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digested with EcoRI and XhoI at 37°C. The pGEX-4T1 vector was digested with the
same enzymes. The digested inserts were purified on a 1% agarose gel and extracted
using the Qiagen gel extraction kit. The purified vector and insert were ligated using the
Takara DNA ligation kit version 1. Plasmids were transformed using DH5α competent
E. coli. Colonies were screened for proper insert by sequencing with the pGEX 5’ and
pGEX3’ primers.
2.2.2 Cell Culture and Transfection
HEK-293 cells were cultured in DMEM-F12 (Gibco) supplemented with 10% serum
and 1% penicillin-streptomycin. HEK-293 cells were cultured in a 5% CO2 incubator at
37°C. HEK-293 cells were transfected using the following protocol: Cells were seeded
on 35 mm tissue culture dishes at 70-80% confluency. The next day the cells were
washed with culture media containing no antibiotics, then incubated with 1.5 mL of the
antibiotic free media. The transfection mix was set up in two tubes. The first tube
contained 200 μL of OptiMEM media and 1μg DNA. The second tube contained 200 μL
of OptiMEM media and 2.5 μL of Lipofectamine™ 2000 transfection reagent
(Invitrogen). These tubes were mixed gently, then allowed to incubate at room
temperature for 20 minutes. Following incubation, the contents of the tube containing the
transfection reagent was added to the tube containing the DNA mixture. The tube was
mixed gently and allowed to incubate at room temperature for 30 minutes. The
transfection mixture was then added to the cell culture dishes in a drop wise fashion and
incubated at 37°C for 24 hours.
2.2.3 Pull Down Assay
HEK-293 cells were transfected with pTriEx NS1 constructs using Lipofectamine
2000 (Invitrogen). Twenty-four hours post transfection the cells were washed in PBS and
lysed in lysis buffer (PBS containing 0.2% Triton-X-100 and protease inhibitors
(aprotinin [1μg/mL], leupeptin [1μg/mL], pepstatin [1μg/mL], and
phenylmethanesulfonyl fluoride (PMSF) [500 μM])). Cell lysate was mixed at 4˚C for 15
minutes then centrifuged (13,000 rpm) for 10 minutes. S-Protein Agarose beads
(Novagen, Darmstadt, Germany) were added to the cleared cell lysate and mixed at room
temperature for 1 hour. S-Protein agarose beads were centrifuged at 3000 rpm and
washed 3 times with lysis buffer. Proteins were eluted from S-Protein agarose beads with
Laemmli sample buffer. Eluates were separated on a 4-15% gel, transferred to a PVDF
membrane by Western, and immunoblotted with anti-SAP-97 antibody (Stressgen, Ann
Arbor, MI). The image of this Western blot can be seen in Figure 2.3.
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Figure 2.3 Pulldown of SAP-97 in HEK-293 cells transiently transfected with
NS1 constructs.
HEK-293 cells were transiently transfected with pTriEX-NS1 constructs. NS1 was
pulled down using S-Protein agarose beads. Eluted protein was transferred by
Western Blot and probed with anti-SAP-97 antibody.

21

2.2.4 Pairwise Binding Assay
GST-SAP-97 PDZ proteins were purified from transformed DH5α E. coli bacteria.
Protein expression was induced using isopropyl β-D thiogalactopyranoside (IPTG) (200
μM final concentration). Bacteria were pelleted by centrifugation at 4000 rpm for 30
minutes. Bacterial pellets were frozen at -80°C. Bacterial pellets were resuspended in
lysis buffer (50 mM Tris base, 1 mM EDTA, and 10% sucrose) supplemented with
protease inhibitors (aprotinin [1μg/mL], leupeptin [1μg/mL], pepstatin [1μg/mL], and
PMSF [500 μM]). Lysozyme (1mg/mL final concentration) was added to the
resuspended bacteria and allowed to mix at 4°C for 30 minutes. Subsequently, 10%
NP40 (20μL/mL) was added to the suspension and allowed to mix at 4°C for 30 minutes.
The suspension was then cleared by centrifugation at 20,000 rpm for 30 minutes at 4°C.
Glutathione beads (50% slurry) were then added to the cleared supernatant and allowed
to mix for 2 hours at 4°C. Glutathione beads were retrieved by centrifugation at 3,000
rpm and washed with 0.2% Triton-X-100 in PBS 3 times, followed by a wash with PBS
plus protease inhibitors. A 20 μL sample of the protein bound to the glutathione beads
were eluted using Laemmli sample buffer and run on a 4-15% gel to visualize the
quantity and quality of the purified protein (Figure 2.4). Proteins were eluted from the
glutathione beads using 10 mM glutathione (pH 7.5). Glutathione was subsequently
dialyzed away from the proteins using 3 changes of PBS. The concentration of purified
proteins was estimated using the Bradford protein estimation assay.
His-S-NS1 proteins were purified using a similar protocol, with a few notable
exceptions. Bacterial pellets were resuspended in resuspension buffer (25 mM HEPES
and 400 mM potassium chloride (KCl)). The pH of the resuspension buffer was adjusted
to 7.4 using potassium hydroxide (KOH). Just before use, 5 mM beta-mercaptoethanol
(βME) was added to the resuspension buffer (final concentration of 0.39 μL/mL). TritonX-100 was added to bacterial pellet (final concentration 2.1%) instead of NP40. Talon
beads (50% slurry) were added to the cleared supernatant and allowed to mix at 4°C for
30 minutes. Recovered Talon beads were washed one time in 0.2% Triton-X-100 in
PBS, then 4 times in PBS supplemented with protease inhibitors (aprotinin [1μg/mL],
leupeptin [1μg/mL], pepstatin [1μg/mL], and PMSF [500 μM]). A 20 μL sample of the
proteins bound to the Talon beads were eluted using 1 M imidazole, blotted onto a
nitrocellulose membrane and probed with S-HRP antibody to visualize the quantity of the
purified protein (Figure 2.5). Proteins were eluted from the Talon beads using 0.1M
imidazole. The concentrations of purified proteins were estimated using the Bradford
protein estimation assay.
Purified GST-SAP-97 PDZ proteins (2 μg) were incubated with 200 ng of purified
His-S-NS1-WT protein for 1 hour at room temperature. Glutathione-Sepharose beads
(Thermo Scientific) were then added and allowed to mix for an additional hour.
Glutathione beads were spun down, washed 3 times with lysis buffer, and protein was
eluted using Laemmli sample buffer. The resulting protein eluate was separated in 415% SDS-PAGE, transferred to a PVDF membrane, and immunoblotted for NS1 using SHRP (Figure 2.6).
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Figure 2.4. Purified GST-SAP-97 PDZ Proteins.
The individual PDZ domains of SAP-97 were cloned into pGEX4T1. Protein was
expressed in E. coli and purified.
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Figure 2.5. Purified His-S-NS1 Proteins.
The NS1 constructs were cloned into pTriEX4. Protein was expressed in Oragami E.
coli and purified.
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Figure 2.6. Pairwise binding of NS1 and individual PDZ domains of SAP-97.
The purified His-S-NS1-WT protein and the purified individual PDZ domain proteins
of SAP-97 were incubated together in a pairwise binding assay.
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2.2.5 Alpha Screen Assay
AlphaScreenTM association assay for interaction between biotin-NS1-WT (biotin-KM-A-R-T-I-E-S-E-V) peptide and GST SAP-97 PDZs proteins (PDZ 1, PDZ 2 and PDZ
3) was performed using an AlphaScreen Glutathione-S-Transferase (GST) detection kit
(PerkinElmer). Starting from 100 µM of final concentration, biotin-NS1-WT peptide was
serially diluted (in 1/2 log dilution series) in assay buffer (25 mM HEPES, 100 mM
NaCl, 0.1% BSA, 0.05% Tween 20, pH 7.4) containing GST SAP-97 PDZs (100 nM
final concentration). The resulting solutions were incubated at room temperature for 30
minutes. Each sample solution (15 µL) was transferred to a white OptiPlate™-384
microplate (PerkinElmer) in triplicates into which anti-GST acceptor beads (5 µL, 20
µg/mL final concentration) were added and incubated for 30 minutes at room
temperature. Streptavidin donor beads (5 µL, 20 µg/mL final concentration) were then
added and incubated for 1 hour at room temperature. The plate was read on an
EnVision™ 2103 ™ Plate Reader (PerkinElmer). Results of this assay are shown in
Figure 2.7.
The procedure of AlphaScreen competition assay of NS1-WT (K-M-A-R-T-I-E-S-EV), NS1-HuPDZ (K-M-A-R-T-I-R-S-K-V) or NS1-ΔPDZ (Q-K-R-K-M-A-R-T-I-E)
peptide against biotin-NS1-WT peptide binding to GST SAP-97 PDZ 2 protein was
similar to the above described AlphaScreen association assay except that NS1-WT, NS1HuPDZ or NS1-ΔPDZ peptides (final concentrations from 1 mM to 3nM) were diluted in
assay buffer (25 mM HEPES, 100 mM NaCl, 0.1% BSA, 0.05% Tween 20, pH 7.4)
containing GST SAP-97 PDZ 2 (100 nM final concentration) and biotin-NS1-WT peptide
(100 nM final concentration). After the addition of Streptavidin donor beads, the plate
was incubated for 4 hours at room temperature prior to reading. The results of this assay
are shown in Figure 2.8.
2.3 Results and Discussion
We identified that SAP-97, an adherens junction protein with 3 PDZ domains
(Figure 1.2), can complex with NS1 in pull-down assays using HEK-293 cell lysate.
NS1-WT protein is able to pull down SAP-97, while NS1-HuPDZ and NS1-ΔPDZ were
not able to pull down SAP-97 (Figure 2.3), suggesting that the interaction between NS1
and SAP-97 is PDZ motif-dependent. Next, I sought to determine if this interaction was
direct and the minimum domain of SAP-97 required to bind NS1. To accomplish this,
each PDZ domain of SAP-97 was individually cloned, protein purified, and incubated
with NS1-WT in a pairwise binding assay (Figure 2.6) The results show that NS1 binds
the second PDZ domain of SAP-97 (PDZ 2) but does not bind PDZ 1 or PDZ 3 (Figure
2.6). These results are consistent with AlphaScreen analysis, which shows that
biotinylated NS1-WT peptide binds PDZ 2 of SAP-97 but does not bind PDZ 1 or PDZ 3
(Figure 2.7). An AlphaScreen competition assay demonstrated that NS1-HuPDZ and
NS1-ΔPDZ peptides do not compete with biotinylated NS1-WT in binding PDZ 2 of
SAP-97 (Figure 2.8). Using the Alpha Screen assay results, the IC50 of the NS1-WT and
SAP-97 interaction was calculated to be 1.5 μM.
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Figure 2.7. Interaction of biotinylated NS1-WT peptide and individual PDZ
domains of SAP-97 as detected by AlphaScreen.
The purified His-S-NS1-WT protein and the purified individual PDZ domain proteins of
SAP-97 were incubated together in an AlphaScreen assay. The sequence of the NS1-WT
peptide used is biotin- K-M-A-R-T-I-E-S-E-V.
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Figure 2.8. AlphaScreen competition assay between NS1 peptide binding to SAP97 PDZ 2.
AlphaScreen competition assay between NS1 peptides against biotinylated NS1-WT
peptides binding to PDZ 2 of SAP-97. Sequences for the peptides used were as
follows: NS1-WT peptide (K-M-A-R-T-I-E-S-E-V); NS1-HuPDZ peptide (K-M-A-RT-I-R-S-K-V); NS1-ΔPDZ peptide (Q-K-R-K-M-A-R-T-I-E); DMSO was used as
solvent to prepare the peptide solutions.
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CHAPTER 3. SAP-97 LOCALIZATION IS ALTERED IN NS1 TRANSFECTED
CELLS AND H5N1 INFECTED TISSUES
3.1 Introduction
To investigate whether localization of SAP-97 is altered during H5N1 infection,
mice were infected with two H5N1 recombinant viruses. The virus A/Vietnam/1203/04
was utilized. This virus has a natural truncation in the NS1 protein and therefore contains
no PDZ motif and will be referred to as H5N1-NS1-ΔPDZ in this study. A second virus
was also utilized for these studies. The recombinant virus is referred to as H5N1-NS1WT. The H5N1-NS1-WT virus has the background of A/Vietnam/1203/04 with the NS
gene of A/Chicken/Vietnam/C58/04. The NS1 protein of this recombinant virus contains
the PDZ motif ESEV, a PDZ motif commonly found in highly pathogenic avian influenza
viruses. Balb/c mice were infected intranasally with these H5N1 viruses, and at 6 days
post infection the mice were sacrificed. The lungs and intestines were harvested and
fixed in 10% neutral buffered formalin. Paraffin embedded mouse lungs and intestines
were labeled with SAP-97 IgG to study the localization of SAP-97 in these tissues.
3.2 Materials and Methods
3.2.1 Plasmid Construction
To create the plasmids pcDNA3-CFP-NS1-WT and pcDNA3-CFP-NS1-ΔPDZ, a
pcDNA3-CFP construct already in use in the Naren lab was utilized. This plasmid
contains XhoI and KpnI restriction sites 3’ to the CFP insert. Primers created for cloning
NS1 into pcDNA3-CFP contained 5’ XhoI and 3’ KpnI restriction sites. The same
forward primer was used for the construction of both plasmids because these two
constructs only vary in sequence at the 3’ end. The sequence for the forward primer used
was as follows: 5’ CCGCTCGAGCAATGGATTCCAACACTGTGTCA 3’. The
sequences for the reverse primers used were for NS1-WT ( 5’CGG GGTACC TCA AAC
TTC TGA CTC AAT TGT 3’) and for NS1-ΔPDZ (5’ CGG GGTACC TCA CTC AAT
TGT TCT CGC CAT 3’). The templates used for PCR reactions were pTriEX4-NS1-WT
and pTriEX4-NS1-ΔPDZ. PCR products were generated using the following conditions:
2 minute denaturation at 95°C, 30 amplification cycles with an annealing temperature of
68°C and final extension of 72°C for 7 minutes. A 10 μL sample of the complete PCR
reaction was run on a 1% agarose gel to verify that the PCR inserts were of the proper
size. The PCR products were then purified using a Qiagen PCR purification kit and
digested with XhoI and KpnI at 37°C. The pCDNA3-CFP vector was digested with the
same enzymes. The digested vector and inserts were purified on a 1% agarose gel and
extracted using the Qiagen gel extraction kit. The purified vector and insert were ligated
using the Takara DNA ligation kit version 1. Plasmids were transformed using DH5α
competent E. coli. Miniprep DNA was purified from colonies and was screened for the
proper size insert by digesting with XhoI and KpnI (Figure 3.1). The plasmids were
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Figure 3.1 Screened colonies of cloning pCDNA3-CFP-NS1-WT and
pCDNA3-CFP-NS1-ΔPDZ constructs.
Agarose gel to confirm proper size of inserts in the cloning of pCDNA3-CFPNS1-WT and pCDNA3-CFP-NS1-ΔPDZ. Miniprep DNA from select
colonies was digested with XhoI and KpnI. Colonies with proper insert size
were sent for sequencing at the Molecular Resource Center.
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confirmed by sequencing at the Molecular Resource Center at The University of
Tennessee Health Science Center, Memphis, TN with the T7 forward and Sp6 reverse
primers.
3.2.2 Cell Culture and Transfection
Caco-2 cells were grown in DMEM (Gibco) supplemented with 10% FBS. Cells
were cultured in a 5% CO2 incubator at 37°C. Caco-2 cells were transfected using the
following protocol: Cells were seeded on glass cover slips placed inside 35 mm tissue
culture dishes at 70-80% confluency. The next day the cells were washed with culture
media containing no antibiotics, then incubated with 1.5 mL of the antibiotic free media.
The transfection mix was set up in two tubes. The first tube contained 200 μL of
OptiMEM® Reduced Serum Media and 1μg DNA. The second tube contained 200 μL of
Opti-MEM® Reduced Serum Media and 2.5 μL of Lipofectamine™ 2000 Transfection
Reagent (Invitrogen). These tubes were mixed gently, then allowed to incubate at room
temperature for 20 minutes. Following incubation, the contents of the tube containing the
transfection reagent was added to the tube containing the DNA mixture. The tube was
mixed gently and allowed to incubate at room temperature for 30 minutes. The
transfection mixture was then added to the cell culture dishes in a drop wise fashion and
incubated at 37°C for 48 hours.
3.2.3 Animal Infection
Animal studies were approved by the St. Jude Children’s Research Hospital
Institutional Animal Use and Care Committee.
Six week old Balb/c mice were infected with 103 EID50 units of influenza virus
A/Vietnam/1203/04 (H5N1-NS1-ΔPDZ) or with A/Vietnam/1203/04 containing the NS1
gene of A/Chicken/Vietnam/C58/04 (H5N1-NS1-WT) intranasally. Day 6 post infection,
the mice were sedated using avertin and sacrificed. The lungs and intestines were
harvested and fixed using 10% neutral buffered formalin for 2 weeks before being
embedded in paraffin.
3.2.4 Tissue Processing
After 2 weeks fixation in 10% neutral buffered formalin, tissues were dehydrated
through passage of graded alcohol. During the dehydration process, the tissue was
treated with each of the flowing agents for 1 hour: 70% ethanol, 80% ethanol, 2 changes
of 95% ethanol, and 4 changes of 100% ethanol. After dehydration, the tissue was
dealcoholized in xylene, and then infiltrated with paraffin. Four micron sections of the
tissue were mounted on glass laboratory slides for further evaluation.
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3.2.5 Fluorescent Immunohistochemistry
Paraffin embedded tissue sections of normal Balb/c mice and H5N1 infected Balb/c
mice (6 days post infection) were deparaffinized using 3 changes of xylene and
rehydrated through graded ethanol. Heat-induced epitope retrieval was performed using
RTU Rodent Decloaker (Biocare Medical). Sections were incubated with rabbit antiSAP-97 antibody (Santa Cruz, CA) followed by AlexaFluor® 488-conjugated anti-rabbit
IgG. The fluorescence was visualized using a Zeiss LSM 5 laser scanning confocal
microscope, and images were collected using Zeiss LSM 5 Pascal software.
3.2.6 Immunofluorescent Staining of Caco-2 Cells
Caco-2 cells were seeded on coverslips at 80% confluence were incubated overnight.
The following morning, Caco-2 cells were transfected with constructs containing Nterminal CFP tagged NS1-WT or NS1-ΔPDZ (pcDNA3-CFP-NS1-WT or pcDNA3-CFPNS1-ΔPDZ. Forty-eight hours post transfection, the cells were washed 3 times with PBS
and fixed using ice cold acetone methanol (1:1). The cells were rehydrated with 3
washes of PBS, 10 minutes each, then permeabilized using 0.2% Trition-X-100 in PBS
for 5 minutes. Blocking was performed using 4% skim milk in TBST at room
temperature in a humidifying chamber. To stain for the SAP-97 protein, cells were
incubated for 2 hours with mouse anti-SAP-97 antibody (Santa Cruz) at a 1:150 dilution
in 4% milk. After 3 washes in PBS, slides were incubated with the secondary anti-mouse
conjugated AlexaFluor 568 antibody. The secondary antibody was used at a 1:200
dilution in 4% milk. Coverslips were incubated with the secondary antibody for 1 hour at
room temperature in a humidifying chamber in the dark. The fluorescence was visualized
using an Olympus FluoViewTM FV1000 fluorescence microscope. Images were collected
at 40X magnification using SlideBook™ 5.0 imaging software.
3.3 Results and Discussion
In normal mouse lungs, SAP-97 localizes at lateral membranes of alveolar cells
(Figure 3.2), whereas in H5N1-NS1-WT-infected lungs, SAP-97 shows an intracellular
distribution (Figure 3.2). An increased cellular infiltrate can also been seen in the lungs
of H5N1-NS1-WT-infected mice (Figure 3.2), which is a consequence of the disrupted
epithelial barrier. In the lungs of mice infected with H5N1-NS1-ΔPDZ, SAP-97 can still
be seen to localize to lateral membranes of alveoli (Figure 3.2), even though other
pathology, such as dilated airspaces, is present in these tissues.
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Figure 3.2. SAP-97 staining in normal and H5N1 infected mouse lungs.
(A) SAP-97 staining in normal mouse lung showing staining localized to the lateral
membranes of alveolar epithelial cells. (B) Inset of normal mouse lung. (C) SAP-97
staining in H5N1-NS1-ΔPDZ infected mouse lung, demonstrating that SAP-97 is still
localized to the lateral membranes of alveolar cells. (D) Inset of H5N1- NS1-ΔPDZ
infected mouse lung. (E) H5N1-NS1-WT-infected mouse lung, showing diffuse SAP-97
staining that is not restricted to the lateral membranes. (F) Inset of H5N1-NS1-WTinfected mouse lung. All images were collected by confocal microscopy at 40X
magnification.
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The intestinal epithelia of H5N1-NS1-WT-infected mice show SAP-97 distribution
is altered in the tips of the villi compared to uninfected controls (Figure 3.3). The altered
SAP-97 distribution can also be seen in the intestines of mice infected with H5N1-NS1ΔPDZ but appears rarely when compared to the intestines of mice infected with H5N1NS1-WT (Figure 3.3).
In Caco-2 cells, SAP-97 distribution is largely at the lateral membranes at sites of
cell-cell contact, but when Caco-2 cells are transfected with NS1-WT, SAP-97 staining is
observed intracellularly and is absent at sites of cell-cell contact (Figure 3.4).
These findings are of significance as they indicate that in H5N1 infected tissues and
cells expressing NS1-WT the interaction between NS1 and SAP-97 redistributes SAP-97.
This perturbs the junctional integrity of the epithelia and thus causes pulmonary edema in
the lung tissue and diarrhea in the intestines.
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Figure 3.3. SAP-97 staining in proximal small intestine of normal and H5N1 infected
mice.
(A) SAP-97 staining in normal mouse intestine. (B) SAP-97 staining in intestine of
mouse infected with H5N1-NS1-ΔPDZ, showing a re-localization of SAP-97 in a small
area of epithelial disruption. (C) SAP-97 staining in the intestine of H5N1-NS1-WTinfected mouse, showing extensive re-localization of SAP-97 and. widespread disruption
of the epithelial barrier.
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Figure 3.4. SAP-97 staining in NS1 transfected Caco-2 cells.
(A) Caco-2 cells transfected with cyan fluorescent protein (CFP) tagged NS1-ΔPDZ and
immunofluorescently stained with anti-SAP-97 antibody (red). SAP-97 staining is seen
at cell-cell junctions. (B) Caco-2 cells transfected with CFP-NS1-WT and
immunofluorescently stained with anti-SAP-97 antibody (red). SAP-97 staining is not
visible at cell-cell junctions in the presence of NS1-WT. All images were collected by
fluorescent microscopy at 60X magnification.
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CHAPTER 4. NS1 INTERACTION WITH SAP-97 DISRUPTS EPITHELIAL
BARRIER FUNCTION
4.1 Introduction
Given that NS1-WT and SAP-97 are interacting physically, we continued to
investigate whether the interaction plays a functional role in the assembly of epithelial
junctions. To that end, we utilized assays that are commonly used to assess the assembly
and integrity of epithelial junctions. These assays are the calcium switch assay and the
inulin flux assay. Caco-2 cells were chosen for these studies because they are a well
characterized human colonic epithelial cell line that has a similar morphology to the
columnar epithelium of the small intestine [104]. Calu-3 cells were also used in calcium
switch experiments. Calu-3 cells are a serosal lung epithelial cell line that form resistant
monolayers, and it was of interest to see if NS1-WT would act similarly on this cell type.
Thus, we strived to utilize cell lines that would give us relevant information for the two
pathological symptoms of H5N1 that we were most interested in, diarrhea and pulmonary
edema.
4.2 Materials and Methods
4.2.1 Plasmid Construction
The SAP-97 siRNA (5’-GATATCCAGGAACA-3’) and its control scrambled
siRNA (5’-CCATAATACCAGGTATAA-3’) were cloned into the pSuper plasmid
(OligoEngline Corp.) as described previously [105]. These plasmids were a kind gift
from the lab of Dr. Suleiman Bahouth. The pTriEX-NS1 constructs were generated, as
described in Chapter 2.
We obtained, from the lab of Dr. Richard Webby, the pSH1203-NS construct, which
encodes NS1 of influenza A/Vietnam/1203/04. This plasmid was used as a template to
create the pTriEx-4-NS1-VTN and pTriEX-4-NS1-VTN-ESEV constructs by ligationindependent cloning (LIC). The 5’ primer used is the same as the one used for pTriEXNS1-WT cloning since these two genes are identical at the 5’ end. The reverse primer
used to create NS1-VTN was 5’ GAG GAG AAG CCC GGT TCA CCG TTT CTG ATT
TGG AGG G 3’. The reverse primer used to create NS1-VTN-ESEV was 5’ GAG GAG
AAG CCC GGT TCA CAC CTC TCA TTC CCG TTT CTG ATT TGG AGG 3’. NS1-VTN
and NS1-VTN-ESEV were amplified using the polymerase chain reaction (PCR). The
PCR conditions used were as follows: 2 minute denaturation at 95°C, 30 amplification
cycles with an annealing temperature of 62°C, and final extension of 72°C for 7 minutes.
PCR products were run on a 1% agarose gel (Figure 4.1). PCR products of the correct
size were excised from the gel and extracted using QIAquick Gel Extraction Kit (Qiagen)
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Figure 4.1 PCR products for cloning pTriEX-NS1-VTN constructs.
Agarose gel to confirm proper size of PCR products for the cloning of
pTriEX-NS1-VTN and pTriEX-NS1-VTN-ESEV.
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gel extraction kit. Purified PCR products were treated with T4 DNA polymerase at room
temperature for 30 minutes to create overhangs that are compatible with the vector. T4
DNA polymerase was then heat inactivated by incubation for 20 minutes at 75°C. Each
insert was then incubated with pTriEX-4 Ek/LIC vector for annealing. Resulting
plasmids were transformed using NovaBlue competent E.coli. for DNA expression.
DNA was extracted from select colonies using a Qiagen miniprep kit. Clones were
screened for proper sequence at The University of Tennessee Health Science Center’s
Molecular Resource Center using the T7 promoter primer and the TriEx-DOWN primer.
The pTriEx vector has N-terminal his6 and S tags.
4.2.2 Cell Culture and Transfection
Caco-2 cells were grown in DMEM (Gibco) supplemented with 10% FBS. Cells
were cultured in a 5% CO2 incubator at 37°C. Calu-3 cells were grown in MEM (Gibco)
supplemented with 10% FBS and 1% each of sodium pyruvate and non-essential amino
acids.
Caco-2 cells were transfected using the following protocol: Cells were seeded in 60
mm tissue culture dishes at 70-80% confluency. The next day the cells were washed with
culture media containing no antibiotics, then incubated with 1.5 mL of the antibiotic free
media. The transfection mix was set up in two tubes. The first tube contained 200 μL of
OptiMEM media and 1μg DNA. The second tube contained 200 μL of OptiMEM media
and 2.5 μL of Lipofectamine™ 2000 transfection reagent (Invitrogen). These tubes were
mixed gently then allowed to incubate at room temperature for 20 minutes. Following
incubation the contents of the tube containing the transfection reagent is added to the tube
containing the DNA mixture. The tube was mixed gently and allowed to incubate at
room temperature for 30 minutes. The transfection mixture was then added to the cell
culture dishes in a drop wise fashion and incubated at 37°C for 24 hours.
Calu-3 cells were transfected using FuGENE® 6 transfection reagent (Roche). Cells
were seeded on 60mm tissue culture dishes at 50-60% confluence. The next day, cells
were rinsed two times with serum free media, then incubated with serum free media with
no antibiotics for 30 minutes. To set up transfection, 6 μL of FuGENE 6 was added to 94
μL of serum free media, mixed and allowed to incubate for five minutes. After the five
minute incubation, 1 μg of DNA was added to the transfection mix and incubated for 20
minutes. The transfection mix was then added to the cells in a drop wise fashion and
allowed to incubate at 37°C for 24 hours.
4.2.3 Measurements of TER, Calcium Switch Assays and Inulin Flux Assay
Caco-2 cells were transiently transfected with NS1 constructs, SAP-97 siRNA, or
scrambled siRNA using Lipofectamine 2000 (Invitrogen). Twenty-four hours post
transfection, Caco-2 cells were trypsinized, counted and seeded on 12mm polycarbonate
membranes in transwells (Costar) at 2x105 cells/membrane. Calcium switch assays
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performed on Caco-2 cells were done as described previously on the fourth or fifth day
post transfection[106]. On the day of the calcium switch, cells were serum starved for
one hour using glutamine free DMEM. After serum starvation, baseline transepithelial
electrical resistance (TER) measurements were recorded. Caco-2 cells were treated with
4 mM ethyleneglyol-bis(2-aminoethylether)N,N,N′,N′, tetraactetic acid (EGTA) in
DMEM (pH 7.35) in both the apical and basolateral wells to reduce the transepithelial
electrical resistance. Cells were then washed 3 times with DMEM to remove EGTA.
TER was measured at regular intervals after EGTA was removed to monitor
reestablishment of cell junctions. TER was measured using a electric voltometer
purchased from World Precision Instruments.
Calcium switch assays performed in Calu-3 cells were performed using a different
strategy than was used with Caco-2 cells. Calu-3 cells were transfected with NS1
constructs using FuGENE 6 (Roche). Twenty-four hours post transfection, cells were
seeded on 6.5 mm transwells (Costar) at 7.2x104 cells/membrane in low calcium media
(0.5 mM CaCl2, 5% dialyzed FBS, 200 mM L-glutamine, 1% sodium pyruvate, and 1%
penicillin in calcium free DMEM). Twenty-four hours post seed the cells were washed
four times with glutamine free MEM and baseline TER was recorded. After cells were
switched to normal growth media, TER was recorded at 30 min intervals.
Inulin flux assays in Caco-2 cells were performed as described previously on the
fourth or fifth day post transfection [106]. After the calcium switch, cells were incubated
with 0.5 mg/mL fluorescein isothiocyanate-inulin (FITC-inulin) in the basal well. At
various time points 100 ul of media was withdrawn from both the basal and apical wells
and fluorescence was measured using a fluorescence plate reader (BioTEK Instruments).
The excitation of FITC inulin is 488 nm and emission was read at 505 nm. Flux into the
apical well was calculated as percentage of the total fluorescence of the basal well/hr/cm2
of the surface area.
Statistical analyses were done using Student’s t-test (homoscedastic, 2-tailed). A p
value of <0.05 was considered significant. All the results are represented as mean ±
standard error mean.
4.3 Results and Discussion
First, we transfected Caco-2 cells with SAP-97 siRNA or scrambled siRNA to
validate the role of SAP-97 in maintaining adherens junction integrity. Briefly,
transfected cells were plated on transwell inserts, and after they had formed resistant
monolayers, they were treated with EGTA to disrupt cell-cell contacts and monitored for
reestablishment of cell junctions using trans-epithelial resistance (TER) measurements.
As shown in Figure 4.2, in cells transfected with SAP-97 siRNA, junctional formation
was impaired compared to scrambled siRNA transfected cells, as indicated by low TER
values for SAP-97 siRNA transfected cells. This result is consistent with a previous
report that SAP-97 plays a critical role in cell junction formation as measured by TER
[107]. Next, we transfected Caco-2 cells with NS1-WT and monitored reestablishment of
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Figure 4.2 NS1 and SAP-97 siRNA disrupt junctional integrity in transfected
Caco-2 cells.
Transepithelial electrical resistance (TER) measurements in transfected Caco-2 cells
at 90 minutes post calcium switch. Cells were transfected with empty vector
(Vector), pTriEX-NS1-WT (NS1-WT), pSuper -scrambled siRNA (Scrambled) or
pSuper-SAP-97 siRNA (SAP-97 siRNA). Figure is representative of three separate
experiments. n=3 for each experiment. *p<0.05
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TER after calcium switch. The result clearly shows that junctional assembly of NS1-WT
transfected cells are impaired compared to vector transfected cells; however, cells
transfected with NS1-HuPDZ or NS1-ΔPDZ are not impaired in reestablishing cell-celljunctions (Figure 4.2 and Figure 4.3).
A similar trend was observed in polarized Calu-3 cells transfected with NS1-WT
(Figure 4.4). Notably, the TER of Calu-3 cells transfected with NS1-ΔPDZ is similar to
vector transfected cells (Figure 4.4). This result indicates that the PDZ motif-dependent
interaction between NS1-WT and SAP-97 disrupts the assembly of epithelial junctions.
This hypothesis was further supported by results of inulin flux assays in which Caco2 cells were transfected with NS1-WT. The inulin flux assay measures the ability of a
large molecule (inulin Mr ≈ 5000) to move from the basolateral to apical side of the cell
monolayer. Due to its large size, inulin will only be able to move across the epithelial
cell monolayer if the barrier is compromised. As can be seen in Figure 4.5, NS1-WT
transfected cells demonstrate higher rates of inulin flux compared to cells transfected
with vector, indicating that juctional integrity is impaired in these cells (Figure 4.5).
However, Caco-2 cells transfected with NS1-ΔPDZ showed similar inulin flux rates to
cells transfected with vector. Taken together, the data indicate that the PDZ motifdependent interaction of NS1-WT and SAP-97 disrupts the functional assembly of
epithelial junctions, a process integral to the integrity of epithelial barriers.
To further examine the importance of the PDZ motif in the disruption of functional
cell-cell junctions, other NS1 constructs were created from the NS1 gene of the virus
A/Vietnam/1203/04. This construct was named NS1-VTN. The NS1 protein of the
Vietnam virus has a truncation of the last 10 amino acids and therefore does not contain a
PDZ motif. In addition to this early stop codon, the NS1 of the Vietnam virus has 5
additional amino acid changes when compared to the NS1 protein of
A/Chicken/Vietnam/C58/04 (NS1-WT). An additional construct was created in which
the PDZ motif ESEV was added to the end of the VTN protein. This construct was
named NS1-VTN-ESEV. Both of these constructs were tested in calcium switch assays
in Caco-2 cells and compared to NS1-WT and NS1-ΔPDZ. As can be seen in Figure 4.6,
NS1-VTN, which has no PDZ motif, behaves similarly to NS1-ΔPDZ. Reestablishment
of cell junctions is not impaired in the presence of these two proteins (NS1-ΔPDZ and
NS1-VTN). However, when the PDZ motif is introduced to the NS1-VTN protein,
epithelial junction formation is impaired similarly to NS1-WT (Figure 4.6). This result
is evidence that the PDZ motif of NS1 plays a critical role in the disruption of the
epithelial barrier. Taken together, the data indicate that the PDZ motif-dependent
interaction of NS1-WT and SAP-97 disrupts the functional assembly of epithelial
junctions, a process integral to the integrity of epithelial barriers.
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Figure 4.3 NS1 disrupts junctional integrity in transfected Caco-2 cells.
Transepithelial electrical resistance (TER) measurements in transfected Caco-2 cells
after 90 minutes after EGTA disruption of the cell junctions. NS1-WT (WT)
transfected cells display much lower TER values than vector transfected controls
(V). NS1-HuPDZ (Hu) and NS1-ΔPDZ (Δ) transfected cells are not statistically
different from vector controls (V). Figure is representative of two separate
experiments. n=4 for each experiment. *p<0.05
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Figure 4.4 NS1 disrupts junctional integrity in transfected Calu-3 cells.
TER in transfected Calu-3 cells after switch from low calcium media to normal
growth media. Figure is representative of three separate experiments. n=3 for each
experiment. *p<0.05 **p<0.005
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Figure 4.5 Inulin Flux in NS1 transfected Caco-2 cells.
Inulin flux measurements in Caco-2 cells transfected with vector (V), NS1-WT (WT),
or NS1-ΔPDZ (Δ) post calcium switch. Flux values between vector and NS1-ΔPDZ
transfected cells are not significant. *p<0.05
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Figure 4.6 Calcium switch assay in NS1-VTN and NS1-VTN-ESEV transfected
Caco-2 cells.
TER measurements in transfected Caco-2 cells after 90 minutes after recovery from
EGTA disruption of the cell junctions. NS1-ΔPDZ (Δ) and NS1-VTN (VTN) transfected
cells show little inhibition of recovering cell-cell junctions after treatment, while NS1WT (WT) and NS1-VTN-ESEV (V-ESEV) transfected cells are markedly inhibited in
their ability to establish cell-cell junctions. Figure is representative of two separate
experiments. n=4 for each experiment. *p<0.005
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CHAPTER 5. THE PDZ MOTIF OF NS1 ACTS AS A VIRULENCE FACTOR IN
H5N1 INFECTED TISSUES
5.1 Introduction
The PDZ motif of NS1 has previously been postulated to modulate virulence in
influenza viruses of avian origin [69,71]. To characterize the pathogenicity of H5N1
virus containing the PDZ motif in the NS1 protein, the virus A/Vietnam/1203/04 was
utilized. This virus has a truncated NS1 protein and thus has no PDZ motif and will be
referred to as H5N1-NS1-ΔPDZ in this study. Using the same background
(A/Vietnam/1203/04), a recombinant virus containing the NS gene of
A/Chicken/Vietnam/C58/04 was engineered. The NS1 protein of this recombinant virus
contains the PDZ motif ESEV commonly found in highly pathogenic avian influenza
viruses. The recombinant virus was referred to as H5N1-NS1-WT in these studies.
5.2 Materials and Methods
5.2.1 Animal Studies
Six week old Balb/c mice were infected with 103 units of influenza virus
A/Vietnam/1203/04 (H5N1-NS1-ΔPDZ) or with A/Vietnam/1203/04 containing the NS1
gene of A/Chicken/Vietnam/C58/04 (H5N1-NS1-WT) intranasally. Day 6 post infection,
the mice were sedated using avertin and sacrificed. The lungs and intestines were
harvested and fixed using 10% neutral buffered formalin then embedded in paraffin.
Paraffin sections were stained with hematoxylin and eosin (H&E) for evaluation.
5.2.2 Tissue Processing
After two weeks fixation in 10% neutral buffered formalin, tissues were dehydrated
through passage of graded alcohol. During the dehydration process, the tissue was
treated with each of the flowing agents for 1 hour: 70% ethanol, 80% ethanol, two
changes of 95% ethanol, and four changes of 100% ethanol. After dehydration, the tissue
was cleared in xylene, and then infiltrated with paraffin. Four micron sections of the
paraffin embedded tissue were mounted on glass laboratory slides for further evaluation.
A routine hematoxylin and eosin staining procedure was used to stain paraffin
embedded tissue sections. First the sections were deparaffinized using three changes of
xylene at 5 minutes each. Sections were then rehydrated by passage through graded
alcohols for 2 minutes each. These included two changes of 100% ethanol, 95% ethanol,
and 80% ethanol. The slides were then rinsed in water. To stain cell nuclei, slides were
incubated for 2 minutes in Harris’s hematoxylin solution. Excess hematoxylin was
removed by rinsing slides in tap water and decolorized by incubating slides in 0.5% acid
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alcohol for a few seconds. Color of hematoxylin was adjusted by incubating slides for 1
minute in Scott’s Bluing Reagent. The cytoplasm of cells was counterstained by
incubating slides with 0.5% alcoholic eosin for 1 minute. Tissue sections were then
dehydrated by passage through graded ethanol for 1 minute each (two changes of 95%
ethanol, and three changes of 100% ethanol). Tissue sections were then cleared by
passage through three changes of xylene before being mounted with permanent mounting
media.
5.2.3 Pathology Scoring
Paraffin sections were stained with hematoxylin and eosin for evaluation. For lung
pathology scores, each lobe of infected lungs was examined and given severity scores for
interstitial infiltrate and alveolar infiltrate. A score of 0 was given to normal tissues.
Tissues that were mildly affected, moderately affected, or severely affected were given
scores of 1, 2, and 3, respectively.
Each affected area of intestinal villi in infected mice was viewed at high power
magnification (40X). Only affected areas of villi were examined. The percentages of
affected villi were counted for each field. Areas that had 30-45% edematous tissue were
given a score of 1, while areas with 46-60% edematous tissue, areas with 61-75%
edematous tissue, and areas with 76-100% edematous tissue were given scores of 2, 3,
and 4, respectively. The number of fields counted for mice infected with H5N1-NS1ΔPDZ (n=6) was less than those for H5N1-NS1-WT (n=17) due to less of the tissue
displaying pathology. Each tissue section was counted only once.
Pathology scores were assigned by a medical pathologist who had no previous
knowledge of the aims of our study.
5.2.4 Immunohistochemical Staining of H5N1 Antigen
Staining for influenza A virus was performed in the same tissues that were stained
with hematoxylin and eosin for pathologic evaluation. Paraffin embedded tissue sections
of normal Balb/c mice, H5N1-NS1-WT, and H5N1-NS1-ΔPDZ infected Balb/c mice (six
days post infection) were deparaffinized, using three changes of xylene, and rehydrated
through graded ethanol (two changes of 100% ethanol, 95% ethanol, 70% ethanol, then
water). Sections were treated with peroxidized I (Biocare Medical) for 5 minutes to
reduce background staining by endogenous peroxidases in the tissue. Heat induced
epitope retrieval was performed by pressure cooking slides in Borg Decloaker (Biocare
Medical). Rodent block M (Biocare Medical) was utilized for the blocking buffer and
was carried out at room temperature in a dark humidifying chamber. Sections were
incubated with antibody against influenza A (US Biological) diluted 1:1000 in DaVinci
green antibody diluent (Biocare Medical) for 2 hours at room temperature in a dark
humidifying chamber. Primary antibody was washed from the slides in 2 changes of
TBS (tris buffered saline). The secondary antibody incubation utilized biotin conjugated
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donkey anti-goat secondary antibody (Santa Cruz) diluted 1:200 in DaVinci green
antibody diluent. Vectastain Elite ABC kit (Vector Laboratories) and DAB Chromagen
Kit (Biocare Medical) were used to visualize the protein. Slides were counterstained with
Gill’s Hematoxylin. Color of hematoxylin was adjusted by incubating slides for 1 minute
in Scott’s Bluing reagent. Tissue sections were then dehydrated by passage through
graded ethanol for 1 minute each (two changes of 95% ethanol, and three changes of
100% ethanol). Tissue sections were then cleared by passage through three changes of
xylene before being mounted with permanent mounting media.
5.3 Results and Discussion
To characterize the pathogenicity of H5N1 virus containing the PDZ motif in the
NS1 protein, the virus A/Vietnam/1203/04 was utilized. This virus, referred to as H5N1NS1-ΔPDZ, has a truncated NS1 protein and thus has no PDZ motif. Using the same
background (A/Vietnam/1203/04), a recombinant virus containing the NS gene of
A/Chicken/Vietnam/C58/04 was engineered. The NS1 protein of this recombinant virus
contains the PDZ motif ESEV, a PDZ motif commonly found in highly pathogenic avian
influenza viruses. The recombinant virus is referred to as H5N1-NS1-WT in these
studies. Balb/c mice were infected intranasally. At 6 days post infection, the mice were
sacrificed and the lung and intestines were harvested for histological analysis.
Hematoxylin and eosin staining of the tissues revealed multi-focal lesions and
pulmonary edema in H5N1-NS1-WT-infected lungs (Figure 5.1). Severe alveolitis,
primary viral pneumonia, and dilated airspaces were observed in the H5N1-NS1- nfected
lung tissues (Figure 5.1). Cellular infiltrate of lung tissues and hemorrhage into
airspaces were also commonly observed (Figure 5.1). These disease states are evidence
that the epithelial barrier function in the lung has been compromised. To evaluate disease
pathology, each lobe of the infected lungs was examined and given a score to reflect the
severity of the interstitial and alveolar infiltrate. Lungs of mice infected with H5N1NS1-WT tended to have higher scores in both the severity of interstitial and alveolar
infiltrates than lungs of mice infected with H5N1-NS1-ΔPDZ (Figure 5.2).
Immunohistological staining for the influenza A revealed that virus was present in both
H5N1-NS1-WT and H5N1-NS1-ΔPDZ lungs (Figure 5.3); therefore, the difference in
pathology is not due to differences in infectivity of the two viruses.
Pathology in the small intestines of H5N1-NS1-WT-infected mice included edema in
the tips of the lamina propia. Both intercellular and intracellular edema could be seen at
the tips of the villi (Figure 5.4). The small intestines of mice infected with H5N1-NS1ΔPDZ were only mildly focally affected (Figure 5.4). An evaluation of the percentage of
affected villi in each high powered field revealed that H5N1-NS1-WT-infected intestines
tended to have greater percentages of affected villi per field (Figure 5.5).
The differences seen in the pathology of tissues of mice infected with the virus
H5N1-NS1-WT versus tissues of mice infected with H5N1-NS1-ΔPDZ gives clear

52

Figure 5.1 Pathology of H5N1 infection in mouse lungs.
(A) Uninfected mouse lung. (B) Lung of H5N1-NS1-WT-infected mouse at 6 days
post infection showing viral pneumonia and pulmonary edema. (C) Lung of H5N1NS1-ΔPDZ-infected mouse at 6 days post infection displaying little inflammation.
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Figure 5.2 Lung pathology scoring of H5N1 infection in mouse lungs.
(A) Interstitial infiltrate severity scores of H5N1-NS1-WT (n=9) and H5N1-NS1ΔPDZ-infected lung lobes (n=7) examined. (B) Alveolar infiltrate severity scores of
H5N1-NS1-WT (n=9) and H5N1- NS1-ΔPDZ (n=7) lung lobes examined. The first
two points overlap but have been adjusted in order for both groups to be seen.
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Figure 5.3 Influenza A antigen staining in H5N1 infected mouse lungs.
(A) Influenza A antigen (DAB chromagen, brown color) staining in uninfected
mouse lung. (B) Influenza A antigen staining in H5N1-NS1-WT and (C) H5N1-NS1ΔPDZ infected mouse lungs. Sections were counterstained with hematoxylin.

55

Figure 5.4 Pathology of H5N1 infection in mouse intestines.
(A) Normal mouse small intestine. (B) Small intestine of H5N1-NS1-WT-infected
mouse showing intracellular and intercellular edema in the epithelial layer and the
lamina propia. (C) Small intestine of mouse infected with H5N1-NS1-ΔPDZ
showing only mild focal edema. (D) Proximal small intestine of H5N1-NS1-WTinfected mouse in which both crypts and villi can be seen. (E) Proximal small
intestine of H5N1-NS1-ΔPDZ-infected mouse in which both crypts and villi can be
seen.

56

Figure 5.5 Pathology scoring of edematous tissue in intestines of mice infected
with H5N1.
Edematous intestinal tissue scores of mice infected with H5N1-NS1-WT or H5N1NS1-ΔPDZ.
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evidence that the PDZ motif of NS1 acts as a virulence factor in avian H5N1 influenza
viruses.
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CHAPTER 6. DISCUSSION
Clinical features of the H5N1 virus in human infection include respiratory symptoms
and diarrhea, two disease states in which epithelial barrier function is disrupted [21].
Autopsies of H5N1 victims have revealed diffuse alveolar damage, edema, fibrous
exudates, hyaline membranes, and hyperplasia of type II pneumocytes in the lungs
[22,24,25]. Pathology has also been noted in other organs such as the spleen, bone
marrow, and lymph nodes [22,24]. Our study focuses on the clinical features of
pulmonary edema and diarrhea and therefore the lung and intestines.
The aim of this study was to define how PDZ motif-mediated interactions of NS1
contribute to the pathogenicity of the virus, particularly in the lung and intestine. We
sought to examine whether the disease phenotype was altered in the presence or absence
of the PDZ motif of NS1. Balb/c mice infected with H5N1 showed more severe disease
pathology when infected with H5N1-NS1-WT, a virus that contains the PDZ motif ESEV
in NS1, as compared to mice infected with H5N1-NS1-ΔPDZ (a virus that has no PDZ
motif in the NS1 protein). Pathology findings include primary viral pneumonia,
pulmonary edema, and alveolitis. The difference in disease phenotype between H5N1NS1-WT- and H5N1-NS1-ΔPDZ-infected mice is best reflected by the disease severity
scores assigned by a pathologist. H5N1-NS1-WT-infected lungs tended to receive higher
scores for interstitial and alveolar infiltrate than did the lungs of mice infected with
H5N1-NS1-ΔPDZ. The difference in disease phenotype is not due to a difference in
infectivity of the two viruses, as evidenced by our observation that antigen staining for
influenza A virus was robust in both the H5N1-NS1-WT and H5N1- NS1-ΔPDZ mouse
lungs. The intestines of H5N1-infected mice also showed differential disease pathology.
The intestines of mice infected with H5N1-NS1-WT tended to have more edematous villi
than intestines of mice infected with H5N1-NS1-ΔPDZ. It is of importance to note that
the pathologist who analyzed the mouse tissue and assigned pathology scores did so
without previous knowledge of the aim of our study.
There are five amino acid differences in the NS1 proteins of these two viruses
(H5N1-NS1-WT and H5N1-NS1-ΔPDZ), in addition to the truncation mutation found in
NS1 of H5N1-NS1-ΔPDZ. Further, mutations at the C-terminus of NS1 cause mutations
in the NS2/NEP protein due to an overlapping reading frame. The contributions of these
individual mutations to the overall phenotype seen in the pathology studies cannot be
ruled out. However, the differences seen in pathology, taken together with the functional
studies (Figure 4.6), lead us to conclude that the PDZ-binding ligand of NS1 plays the
major role in disrupting the epithelial barrier, thus leading to the differences in pathology
of the two different viruses in the mouse lung and intestine.
Viral antigens and viral RNA have been detected in patient lung, brain, spleen, and
intestine [24,25,27]. A large number of H5N1 patients present with diarrhea; therefore, it
was of interest to further investigate mechanisms behind this disease symptom. One
retrospective report documenting the clinical features of H5N1 in Vietnam found that
diarrhea was more common in fatal than nonfatal H5N1 cases [23]. Viral RNA has also
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been detected in rectal swabs of patients [28,29]. Our efforts to stain for viral antigen in
mouse intestines were only successful when harsh antigen retrieval methods were used.
This left the tissue damaged, and therefore images are not included here. We are
confident that these results are not false-positive staining artifacts, because negative
controls did not stain for the viral antigen. Instead, we think these results represent a
technical limitation in the sensitivity of the immunohistochemistry procedure. The
technical difficulty in IHC staining in intestinal tissue is consistent with reports of human
H5N1 infection in which IHC staining was negative, yet viral RNA was detected in the
same tissues [24,25].
Since the onset of the H5N1 outbreak, global efforts have been aimed at
understanding this highly pathogenic virus. Attempts to elucidate the molecular
mechanisms for viral pathogenesis have been pursued. Among the findings are the single
amino acid change in the RNA polymerase PB2 at position 627 and an amino acid
change at position 66 of the PB1-F2 protein—both of which modulate virulence [30-32].
The hemagglutinin protein also has been shown to be an important mediator of virulence
in H5N1 viruses. Increased cleavability of the receptor by ubiquitous proteases has been
shown to correlate with increased virulence [30,32]. In addition, NS1 has been reported
to play a role in the virulence of H5N1. Single amino acid changes in NS1 at residues 42,
92, and 149 have been found to increase the virulence of H5N1 [33,34,108].
The PDZ motif of NS1 was previously found to modulate virulence of H5N1 in
mice, yet the cellular pathway responsible for this affect was undetermined [71]. Our
work helps bridge this understanding by defining one of the mechanisms by which the
PDZ motif of NS1 is contributing to the pathogenicity of the virus. We are the first to
show that NS1 can interact with SAP-97 and that this interaction has functional
consequence in disrupting epithelial barrier integrity.
In this study, our aim was to understand how the host and viral protein-protein
interactions of NS1, through its PDZ-binding motif, may contribute to the disease
phenotype of pulmonary edema and diarrhea. Here, we characterize the interaction
between NS1 and the adherens junction protein SAP-97. SAP-97 function is crucial for
adherens junction integrity, and therefore inhibiting this pathway can lead to loss of
epithelial barrier function [85,88,89,92-95].
Based on our data, we conclude that NS1 of H5N1 binds PDZ 2 of SAP-97. The
interaction between NS1 and SAP-97 is PDZ motif-dependent; NS1 with an altered PDZ
motif (NS1-HuPDZ) and NS1 lacking the PDZ binding motif (NS1-ΔPDZ) are not able
to bind SAP-97. In virus-infected tissues, where there is evidence of disruption in the
epithelial barriers, the normal distribution of SAP-97 is altered. In NS1-WT-transfected
cells, we demonstrated that the epithelia are delayed in forming cell-cell junctions, as
evidenced by their inability to form resistant monolayers and high rates of paracellular
flux. SAP-97-depleted cells also display delays in junctional formation and have high
paracellular flux rates. This functional data clearly suggests that NS1 is able to inhibit
the establishment of cell junctions through interacting with SAP-97. Therefore, the
interaction between NS1 and SAP-97 has a functional consequence in disrupting the
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adherens junction, thus contributing to the disease severity of the virus. The physical and
functional interaction between NS1 and SAP-97 may help us understand one of
mechanisms by which H5N1-infected tissues accumulate edema that leads to pulmonary
edema in the lung and diarrhea in the intestines.
I propose the following model to explain the mechanism by which NS1 acts on SAP97 to disrupt epithelial barrier integrity. At the epithelial cell membrane, NS1 interacts
with SAP-97 in a PDZ-dependent manner. The binding of NS1 to PDZ 2 of SAP-97
sequesters SAP-97, thus preventing it from participating in the maintenance of the
adherens junction. A loss of SAP-97 at the adherens junction soon leads to disruption in
the integrity of the junctional complex and consequently a loss in the integrity of the
epithelial barrier. The subsequent compromise in the epithelial barrier function
contributes to disease phenotypes seen in H5N1 infection: pulmonary edema in the lung
and diarrhea in the intestines.
The interaction of NS1 of H5N1 and SAP-97 is the only interaction of NS1 with a
host protein that has been investigated. The individual interactions of NS1 with other
host proteins have not been fully defined and the functionally of these interations merits
future investigation. These studies do not rule out the possibility that PDZ motifdependent interactions of NS1 with other proteins of the junctional complex or polarity
proteins may contribute to the disease phenotype observed in these studies. As these
protein-protein interactions are studied the pathogenic mechanisms of the highly virulent
H5N1 virus will be better understood.
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